{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,14]],"date-time":"2026-11-14T18:09:56Z","timestamp":1794679796009,"version":"4.9.1"},"reference-count":8,"publisher":"American Society of Hematology","issue":"3","content-domain":{"domain":["ashpublications.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2006,2,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:p>The age-adjusted incidence of multiple myeloma (MM) is 2-fold higher in African Americans than in whites. A few small studies have reported a higher prevalence of monoclonal gammopathy of undetermined significance (MGUS) in African Americans versus whites. Etiologic factors for MGUS and determinants for transformation of MGUS to MM are unknown. We quantified the prevalence of MGUS and subsequent risk of MM among 4 million African American and white male veterans admitted to Veterans Affairs (VA) hospitals. The age-adjusted prevalence ratio of MGUS in African Americans compared with whites was 3.0 (2.7-3.3 95% confidence interval). Among 2046 MGUS cases, the estimated cumulative risk of MM during the first 10 years of follow-up was similar (P = .37) for African Americans (17%) and whites (15%). In the largest study to date, we suggest that the excess risk of MM in African Americans results from an increase in risk of MGUS rather than an increased risk of progression from MGUS to MM.<\/jats:p>","DOI":"10.1182\/blood-2005-08-3449","type":"journal-article","created":{"date-parts":[[2005,10,7]],"date-time":"2005-10-07T00:14:12Z","timestamp":1128644052000},"page":"904-906","update-policy":"https:\/\/doi.org\/10.1182\/blood.2019cm0000","source":"Crossref","is-referenced-by-count":292,"title":["Risk of monoclonal gammopathy of undetermined significance (MGUS) and subsequent multiple myeloma among African American and white veterans in the United States"],"prefix":"10.1182","volume":"107","author":[{"given":"Ola","family":"Landgren","sequence":"first","affiliation":[{"name":"From the Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, MD; and Section of Hematology, Department of Medicine, Malmo\u0308 University Hospital, University of Lund, Malmo\u0308, Sweden."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gloria","family":"Gridley","sequence":"additional","affiliation":[{"name":"From the Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, MD; and Section of Hematology, Department of Medicine, Malmo\u0308 University Hospital, University of Lund, Malmo\u0308, Sweden."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ingemar","family":"Turesson","sequence":"additional","affiliation":[{"name":"From the Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, MD; and Section of Hematology, Department of Medicine, Malmo\u0308 University Hospital, University of Lund, Malmo\u0308, Sweden."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Neil E.","family":"Caporaso","sequence":"additional","affiliation":[{"name":"From the Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, MD; and Section of Hematology, Department of Medicine, Malmo\u0308 University Hospital, University of Lund, Malmo\u0308, Sweden."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lynn R.","family":"Goldin","sequence":"additional","affiliation":[{"name":"From the Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, MD; and Section of Hematology, Department of Medicine, Malmo\u0308 University Hospital, University of Lund, Malmo\u0308, Sweden."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dalsu","family":"Baris","sequence":"additional","affiliation":[{"name":"From the Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, MD; and Section of Hematology, Department of Medicine, Malmo\u0308 University Hospital, University of Lund, Malmo\u0308, Sweden."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas R.","family":"Fears","sequence":"additional","affiliation":[{"name":"From the Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, MD; and Section of Hematology, Department of Medicine, Malmo\u0308 University Hospital, University of Lund, Malmo\u0308, Sweden."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert N.","family":"Hoover","sequence":"additional","affiliation":[{"name":"From the Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, MD; and Section of Hematology, Department of Medicine, Malmo\u0308 University Hospital, University of Lund, Malmo\u0308, Sweden."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martha S.","family":"Linet","sequence":"additional","affiliation":[{"name":"From the Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, MD; and Section of Hematology, Department of Medicine, Malmo\u0308 University Hospital, University of Lund, Malmo\u0308, Sweden."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"234","reference":[{"key":"2019111711200554500_REF1","unstructured":"Ries LAG, Eisner MP, Kosary CL, et al, eds. SEER Cancer Statistics Review, 1975-2000. Bethesda, MD: National Cancer Institute; 2003."},{"key":"2019111711200554500_REF2","doi-asserted-by":"crossref","unstructured":"Axelsson U, Bachmann R, Hallen J. Frequency of pathological proteins (M-components) in 6,995 sera from an adult population. Acta Med Scand. 1966;179: 235-247.","DOI":"10.1111\/j.0954-6820.1966.tb05453.x"},{"key":"2019111711200554500_REF3","doi-asserted-by":"crossref","unstructured":"Kyle RA, Therneau TM, Rajkumar SV, et al. A long-term study of prognosis in monoclonal gammopathy of undetermined significance. N Engl J Med. 2002;346: 564-569.","DOI":"10.1056\/NEJMoa01133202"},{"key":"2019111711200554500_REF4","doi-asserted-by":"crossref","unstructured":"Hideshima T, Bergsagel PL, Kuehl WM, Anderson KC. Advances in biology of multiple myeloma: clinical applications. Blood. 2004;104: 607-618.","DOI":"10.1182\/blood-2004-01-0037"},{"key":"2019111711200554500_REF5","doi-asserted-by":"crossref","unstructured":"Chng WJ, Van Wier SA, Ahmann GJ, et al. A validated FISH trisomy index demonstrates the hyperdiploid and non-hyperdiploid dichotomy in MGUS. Blood. 2005;106: 2156-2161.","DOI":"10.1182\/blood-2005-02-0761"},{"key":"2019111711200554500_REF6","unstructured":"Singh J, Dudley AW Jr, Kulig KA. Increased incidence of monoclonal gammopathy of undetermined significance in blacks and its age-related differences with whites on the basis of a study of 397 men and one woman in a hospital setting. J Lab Clin Med. 1990;116: 785-789."},{"key":"2019111711200554500_REF7","doi-asserted-by":"crossref","unstructured":"Schechter GP, Shoff N, Chan C, McManus CD, Hawley HP. The frequency of monoclonal gammopathy of unknown significance in Black and Caucasian veterans in a hospital population. In: Obrams GI, Potter M, eds. Epidemiology and Biology of Multiple Myeloma. New York, NY: Springer; 1991: 83-85.","DOI":"10.1007\/978-3-642-76655-8_14"},{"key":"2019111711200554500_REF8","doi-asserted-by":"crossref","unstructured":"Cohen HJ, Crawford J, Rao MK, Pieper CF, Currie MS. Racial differences in the prevalence of monoclonal gammopathy in a community-based sample of the elderly. Am J Med. 1998;104: 439-444.","DOI":"10.1016\/S0002-9343(98)00080-1"}],"container-title":["Blood"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/ashpublications.org\/blood\/article-pdf\/107\/3\/904\/1281421\/zh800306000904.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/ashpublications.org\/blood\/article-pdf\/107\/3\/904\/1281421\/zh800306000904.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,11,17]],"date-time":"2019-11-17T16:20:14Z","timestamp":1574007614000},"score":1,"resource":{"primary":{"URL":"https:\/\/ashpublications.org\/blood\/article\/107\/3\/904\/22154\/Risk-of-monoclonal-gammopathy-of-undetermined"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,2,1]]},"references-count":8,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2006,2,1]]}},"URL":"https:\/\/doi.org\/10.1182\/blood-2005-08-3449","relation":{},"ISSN":["0006-4971","1528-0020"],"issn-type":[{"value":"0006-4971","type":"print"},{"value":"1528-0020","type":"electronic"}],"subject":[],"published":{"date-parts":[[2006,2,1]]}}}